Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats

CONTEXT: Therapeutic doxorubicin administration is restricted as this anticancer drug may be cardiotoxic. The traditional Chinese medicine qiliqiangxin has been approved for clinical treatment of chronic heart failure. OBJECTIVE: To explore the protective effects and molecular mechanisms of qiliqian...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xutao, Chen, Guozhen, Xie, Ying, Jiang, Deyou, Han, Jieru, Chen, Fei, Song, Yunjia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301709/
https://www.ncbi.nlm.nih.gov/pubmed/32429724
http://dx.doi.org/10.1080/13880209.2020.1761403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301709/
https://www.ncbi.nlm.nih.gov/pubmed/32429724
http://dx.doi.org/10.1080/13880209.2020.1761403

Ejemplares similares